L.C. Verhoog

1.7k total citations
16 papers, 1.3k citations indexed

About

L.C. Verhoog is a scholar working on Genetics, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, L.C. Verhoog has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 5 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in L.C. Verhoog's work include BRCA gene mutations in cancer (14 papers), Cancer Genomics and Diagnostics (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). L.C. Verhoog is often cited by papers focused on BRCA gene mutations in cancer (14 papers), Cancer Genomics and Diagnostics (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). L.C. Verhoog collaborates with scholars based in Netherlands, United States and India. L.C. Verhoog's co-authors include E.J. Meijers-Heijboer, Caroline Seynaeve, J.G.M. Klijn, Anja Wagner, Peter Devilee, Cecile T.M. Brekelmans, A. van den Ouweland, J.G.M. Klijn, A.N. van Geel and G Dahmen and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gut.

In The Last Decade

L.C. Verhoog

16 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.C. Verhoog Netherlands 11 1.1k 539 334 296 285 16 1.3k
Leon C. Verhoog Netherlands 8 860 0.8× 411 0.8× 251 0.8× 337 1.1× 209 0.7× 9 1.1k
C.C.M. Bartels Netherlands 10 723 0.7× 378 0.7× 243 0.7× 301 1.0× 198 0.7× 20 943
Bert van Geel Netherlands 7 756 0.7× 358 0.7× 199 0.6× 254 0.9× 160 0.6× 7 896
Kerstin Rhiem Germany 15 572 0.5× 312 0.6× 175 0.5× 184 0.6× 258 0.9× 28 786
DF Easton United Kingdom 7 724 0.7× 291 0.5× 283 0.8× 238 0.8× 318 1.1× 16 940
Kerry Kingham United States 14 648 0.6× 343 0.6× 411 1.2× 172 0.6× 333 1.2× 31 1.0k
Angela George United Kingdom 17 596 0.6× 307 0.6× 144 0.4× 564 1.9× 412 1.4× 60 1.2k
Katrina Lowstuter United States 12 537 0.5× 291 0.5× 216 0.6× 339 1.1× 306 1.1× 18 919
Linda Bradley United States 7 1.2k 1.1× 378 0.7× 330 1.0× 517 1.7× 480 1.7× 11 1.6k
Amie M. Deffenbaugh United States 15 1.7k 1.6× 534 1.0× 451 1.4× 390 1.3× 1.0k 3.6× 19 2.1k

Countries citing papers authored by L.C. Verhoog

Since Specialization
Citations

This map shows the geographic impact of L.C. Verhoog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.C. Verhoog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.C. Verhoog more than expected).

Fields of papers citing papers by L.C. Verhoog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.C. Verhoog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.C. Verhoog. The network helps show where L.C. Verhoog may publish in the future.

Co-authorship network of co-authors of L.C. Verhoog

This figure shows the co-authorship network connecting the top 25 collaborators of L.C. Verhoog. A scholar is included among the top collaborators of L.C. Verhoog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.C. Verhoog. L.C. Verhoog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Elshout, Gijs, Frank J. M. F. Dor, L.C. Verhoog, L Berk, & W. W. Vrijland. (2010). A Dutch patient presenting with a rare clinical syndrome. Gut. 60(9). 1213–1213. 1 indexed citations
2.
Wouters, Michel W.J.M., A.N. van Geel, Marian B. E. Menke‐Pluijmers, et al.. (2007). Should internal mammary chain (IMC) sentinel node biopsy be performed?. The Breast. 17(2). 152–158. 10 indexed citations
3.
Seynaeve, Caroline, L.C. Verhoog, Albertus N. van Geel, et al.. (2004). Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. European Journal of Cancer. 40(8). 1150–1158. 65 indexed citations
4.
Contant, Caroline M. E., Marian B. E. Menke‐Pluijmers, Caroline Seynaeve, et al.. (2002). Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation. European Journal of Surgical Oncology. 28(6). 627–632. 60 indexed citations
5.
Verhoog, L.C., A.M.W. van den Ouweland, E. Berns, et al.. (2001). Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families. European Journal of Cancer. 37(16). 2082–2090. 52 indexed citations
6.
Berns, E., Iris L. van Staveren, L.C. Verhoog, et al.. (2001). Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features. British Journal of Cancer. 85(4). 538–545. 12 indexed citations
7.
Brekelmans, Cecile T.M., Caroline Seynaeve, C.C.M. Bartels, et al.. (2001). Effectiveness of Breast Cancer Surveillance in BRCA1/2 Gene Mutation Carriers and Women With High Familial Risk. Journal of Clinical Oncology. 19(4). 924–930. 233 indexed citations
8.
Meijers-Heijboer, E.J., L.C. Verhoog, Caroline Seynaeve, et al.. (2000). Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. The Lancet. 355(9220). 2015–2020. 225 indexed citations
9.
Verhoog, L.C., Cecile T.M. Brekelmans, Caroline Seynaeve, E.J. Meijers-Heijboer, & J.G.M. Klijn. (2000). Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer. British Journal of Cancer. 83(3). 384–386. 90 indexed citations
10.
Verhoog, L.C., E. Berns, Cecile T.M. Brekelmans, et al.. (2000). Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients.. PubMed. 18(21 Suppl). 119S–24S. 21 indexed citations
11.
Verhoog, L.C., et al.. (2000). Expression profiling of BRCA1 associated breast tumors. Breast Cancer Research. 2(S1). 2 indexed citations
12.
Verhoog, L.C., et al.. (1999). Prophylactic surgery in BRCA1/2 mutation carriers Predictive factors and follow-up. The American Journal of Human Genetics. 65(4). 22. 3 indexed citations
13.
Brekelmans, Cecile T.M., C.C.M. Bartels, Ellen Crepin, et al.. (1999). Screening women with a family history of breast cancer. European Journal of Cancer. 35. S158–S158. 2 indexed citations
14.
Verhoog, L.C., Cecile T.M. Brekelmans, Caroline Seynaeve, et al.. (1999). Survival in Hereditary Breast Cancer Associated With Germline Mutations of BRCA2. Journal of Clinical Oncology. 17(11). 3396–3402. 135 indexed citations
15.
Verhoog, L.C., Caroline Seynaeve, G Dahmen, et al.. (1998). Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. The Lancet. 351(9099). 316–321. 336 indexed citations
16.
Verhoog, L.C., Cecile T.M. Brekelmans, C. Seynaeve, et al.. (1998). Survival and Tumour Characteristics of Breast-Cancer Patients with Germline Mutations of BRCA1. Obstetrical & Gynecological Survey. 53(6). 354–355. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026